Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$793M |
| 2 |
Microsoft
MSFT
|
+$777M |
| 3 |
Coca-Cola
KO
|
+$755M |
| 4 |
Apple
AAPL
|
+$744M |
| 5 |
NVIDIA
NVDA
|
+$718M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Real Estate ETF
VNQ
|
+$251M |
| 2 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$247M |
| 3 |
Oracle
ORCL
|
+$228M |
| 4 |
Vanguard Long-Term Treasury ETF
VGLT
|
+$176M |
| 5 |
MRO
Marathon Oil Corporation
MRO
|
+$140M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.59% |
| 2 | Financials | 12.77% |
| 3 | Consumer Discretionary | 9.88% |
| 4 | Healthcare | 9.85% |
| 5 | Industrials | 8.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2801
Xeris Biopharma Holdings
XERS
$1.39B
| $1.37M | ﹤0.01% |
402,872
-489
| -0.1% | -$1.57K |
|
2802
Mid Penn Bancorp
MPB
$971M
| $1.37M | ﹤0.01% |
47,355
+6,439
| +16% | +$199K |
|
2803
Nektar Therapeutics
NKTR
$2.39B
| $1.36M | ﹤0.01% |
97,744
+799
| +0.8% | +$14.1K |
|
2804
Lands' End
LE
$370M
| $1.36M | ﹤0.01% |
103,401
+695
| +0.7% | +$10.9K |
|
|
AGS
2805
DELISTED
PlayAGS
AGS
| $1.36M | ﹤0.01% |
117,789
+77
| +0.1% | +$892 |
|
2806
Hagerty
HGTY
$1.17B
| $1.35M | ﹤0.01% |
140,037
+8,258
| +6% | +$89.8K |
|
2807
Peoples Financial Services
PFIS
$704M
| $1.35M | ﹤0.01% |
26,345
+704
| +3% | +$35.8K |
|
2808
Coherus Oncology
CHRS
$217M
| $1.35M | ﹤0.01% |
976,857
+12,530
| +1% | +$14.1K |
|
2809
NWPX Infrastructure Inc
NWPX
$1.19B
| $1.34M | ﹤0.01% |
27,848
| – | – |
|
2810
Paysafe
PSFE
$414M
| $1.33M | ﹤0.01% |
77,811
| – | – |
|
2811
BigBear.ai
BBAI
$1.34B
| $1.33M | ﹤0.01% |
298,596
+8,879
| +3% | +$20.1K |
|
|
MODV
2812
DELISTED
ModivCare
MODV
| $1.33M | ﹤0.01% |
112,043
-35,391
| -24% | -$560K |
|
2813
Wheels Up
UP
$208M
| $1.33M | ﹤0.01% |
40,159
+318
| +0.8% | +$13.4K |
|
2814
Rackspace Technology
RXT
$1.05B
| $1.32M | ﹤0.01% |
595,860
+5,136
| +0.9% | +$13K |
|
|
PLL
2815
DELISTED
Piedmont Lithium
PLL
| $1.31M | ﹤0.01% |
149,918
-4,963
| -3% | -$58.2K |
|
2816
Virgin Galactic
SPCE
$328M
| $1.3M | ﹤0.01% |
221,882
+34,514
| +18% | +$230K |
|
|
RAPP
2817
Rapport Therapeutics
RAPP
$1.96B
| $1.3M | ﹤0.01% |
73,509
+363
| +0.5% | +$8.04K |
|
2818
Rigel Pharmaceuticals
RIGL
$681M
| $1.3M | ﹤0.01% |
77,407
| – | – |
|
2819
Blink Charging
BLNK
$74.3M
| $1.3M | ﹤0.01% |
935,866
+116,758
| +14% | +$206K |
|
|
TRML
2820
DELISTED
Tourmaline Bio
TRML
| $1.3M | ﹤0.01% |
64,059
+488
| +0.8% | +$12.3K |
|
2821
Perspective Therapeutics
CATX
$332M
| $1.3M | ﹤0.01% |
406,966
-26,556
| -6% | -$217K |
|
2822
Astronics
ATRO
$3.43B
| $1.3M | ﹤0.01% |
97,408
+5
| +0% | +$73 |
|
2823
Bar Harbor Bankshares
BHB
$665M
| $1.29M | ﹤0.01% |
42,132
+943
| +2% | +$31.2K |
|
2824
ProKidney
PROK
$316M
| $1.28M | ﹤0.01% |
759,787
+10,069
| +1% | +$18.2K |
|
|
CUK
2825
DELISTED
Carnival PLC
CUK
| $1.28M | ﹤0.01% |
57,019
+8,974
| +19% | +$191K |
|
Similar funds
Charles Schwab's Q4 2024 Portfolio in Review
As of Q4 2024, Charles Schwab held 3,563 positions worth $542B, up 3.5% from $524B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Charles Schwab deployed $17.7B of net new capital in Q4 2024, opening 62 new positions and adding to 2,296 existing holdings. Its largest new stake was Janus Henderson AAA CLO ETF: 3,465,261 shares worth $176M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Vanguard Mortgage-Backed Securities ETF, an estimated $247M trimmed.
- Charles Schwab's largest Q4 2024 buy was Janus Henderson AAA CLO ETF: 3,465,261 shares worth $176M.
- Charles Schwab added most to Amgen in Q4 2024, an estimated $793M increase.
- Charles Schwab's biggest Q4 2024 reduction was Vanguard Mortgage-Backed Securities ETF, cutting an estimated $247M.
- Charles Schwab fully exited Vanguard Real Estate ETF in Q4 2024, selling an estimated $251M.
- Charles Schwab's ten largest holdings make up 23% of its $542B portfolio in Q4 2024.
- Charles Schwab opened 62 new positions and closed 70 in Q4 2024.
- Charles Schwab's portfolio value rose 3.5% quarter-over-quarter to $542B.
Based on Charles Schwab's 13F filing for Q4 2024, filed 6 Feb 2025.